Funded Artificial Intelligence Startups in Salt Lake City
Salt Lake City AI funding here is dominated by a single disclosed outlier: Recursion Pharmaceuticals shows a $239M round dated 2020-09-09, far above the ne…
Salt Lake City AI funding here is dominated by a single disclosed outlier: Recursion Pharmaceuticals shows a $239M round dated 2020-09-09, far above the next-largest disclosed amount of $150M (also Recursion Pharmaceuticals, dated 2022-10-25). The rest of the disclosed rounds largely cluster below $115M, with several in the $20M–$74M range (e.g., Jump $20M on 2025-02-03; PassiveLogic $74M on 2025-09-20; Zanskar $115M on 2026-01-21).
Stage and disclosure patterns also skew the picture. Of 14 rows, 6 are “Series Unknown” and 1 is “undisclosed” (7 of 14 entries have no disclosed series or amount), while the disclosed ones still show an uneven stage mix: Series C appears twice (Zanskar $115M on 2026-01-21; PassiveLogic $74M on 2025-09-20) and Series A appears twice (Jump $20M on 2025-02-03; MURF.AI $10M on 2022-09-21). Temporally, the latest covered entry is Vanilla on 2026-06-30, while the oldest is the 2020-09-09 Recursion Pharmaceuticals equity event; the data span roughly 5.8 years, with many entries concentrated from 2023-01-19 onward (e.g., Altitude AI $4M on 2023-01-19; OMNIQ $3M on 2023-10-06).
Most recent rounds
14 shownRelated listings
Frequently asked
What’s the largest disclosed funding event in this Salt Lake City AI list, and how separated is it from the next-largest disclosed amount?
Recursion Pharmaceuticals’ $239M round dated 2020-09-09 is the largest disclosed amount in the 14-row view, dwarfing the next-largest disclosed amount of $150M (Recursion Pharmaceuticals, 2022-10-25). Most other disclosed entries sit well below $115M, including Zanskar’s $115M on 2026-01-21 and PassiveLogic’s $74M on 2025-09-20.
How much of the list clusters in recent years versus earlier entries?
After 2023-01-19 (Altitude AI $4M), the table shows a dense stretch of entries through 2026, including Gauge $9M on 2023-03-14, OMNIQ $3M on 2023-10-06, Jump $20M on 2025-02-03, PassiveLogic $74M on 2025-09-20, and Vanilla on 2026-06-30. The earliest covered date is 2020-09-09 (Recursion Pharmaceuticals $239M), creating a long tail before that 2023-onward cluster.
Are disclosure or series labels concentrated in a way that limits comparisons across companies?
Seven of 14 rows either have “Series Unknown” (6 entries) and/or “undisclosed” amounts (1 entry), including Vanilla (undisclosed on 2026-06-30) and DeepSee.ai (undisclosed series on 2026-01-08). Among the disclosed-amount rows, stage labels are more selective: Series C appears twice (Zanskar on 2026-01-21 with $115M; PassiveLogic on 2025-09-20 with $74M), while Series A also appears twice (Jump on 2025-02-03 with $20M; MURF.AI on 2022-09-21 with $10M).
Which entries are nearest to the top of the date range, within the most recent ~180 days shown?
Within roughly the last 180 days of the displayed range, late-2025 through mid-2026 includes Moises ($30M) on 2025-05-12, Zanskar ($115M) on 2026-01-21, Vanilla (undisclosed) on 2026-06-30, and DeepSee.ai (undisclosed amount) on 2026-01-08. Earlier 2025 entries like Jump ($20M) on 2025-02-03 and PassiveLogic ($74M) on 2025-09-20 also sit close to that edge.
Are there outlier patterns beyond the largest deal amount?
Two Recursion Pharmaceuticals rows create a second magnitude outlier relative to the rest: $150M on 2022-10-25 and $239M on 2020-09-09. On the lower end, the smallest disclosed amount is $1M (Yipy on 2026-01-13), while several other disclosed amounts cluster near $3M–$4M (Qualiti $3M on 2023-12-13; OMNIQ $3M on 2023-10-06; Altitude AI $4M on 2023-01-19).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.